The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...
The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...
Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after ...
Several news outlets, including Politico, CNN and the Washington Post, reported on December 2 that Food and Drug ...
Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...
The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab monkeys in preclinical ...
Rick Pazdur had clashed with Trump officials on the legality and pace of their initiatives. He could still withdraw his ...
FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review.
The top drug regulator at the Food and Drug Administration, Richard Pazdur, has decided to retire from the agency just three ...
Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...
Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to retire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback